Abstract |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible coronavirus responsible for the global COVID-19 pandemic. Herein, we provide evidence that SARS-CoV-2 spreads through cell-cell contact in cultures, mediated by the spike glycoprotein. SARS-CoV-2 spike is more efficient in facilitating cell-to-cell transmission than is SARS-CoV spike, which reflects, in part, their differential cell-cell fusion activity. Interestingly, treatment of cocultured cells with endosomal entry inhibitors impairs cell-to-cell transmission, implicating endosomal membrane fusion as an underlying mechanism. Compared with cell-free infection, cell-to-cell transmission of SARS-CoV-2 is refractory to inhibition by neutralizing antibody or convalescent sera of COVID-19 patients. While angiotensin-converting enzyme 2 enhances cell-to-cell transmission, we find that it is not absolutely required. Notably, despite differences in cell-free infectivity, the authentic variants of concern (VOCs) B.1.1.7 (alpha) and B.1.351 (beta) have similar cell-to-cell transmission capability. Moreover, B.1.351 is more resistant to neutralization by vaccinee sera in cell-free infection, whereas B.1.1.7 is more resistant to inhibition by vaccinee sera in cell-to-cell transmission. Overall, our study reveals critical features of SARS-CoV-2 spike-mediated cell-to-cell transmission, with important implications for a better understanding of SARS-CoV-2 spread and pathogenesis.
|
Authors | Cong Zeng, John P Evans, Tiffany King, Yi-Min Zheng, Eugene M Oltz, Sean P J Whelan, Linda J Saif, Mark E Peeples, Shan-Lu Liu |
Journal | Proceedings of the National Academy of Sciences of the United States of America
(Proc Natl Acad Sci U S A)
Vol. 119
Issue 1
(01 04 2022)
ISSN: 1091-6490 [Electronic] United States |
PMID | 34937699
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2021 the Author(s). Published by PNAS. |
Chemical References |
- Antibodies, Neutralizing
- Antibodies, Viral
- Spike Glycoprotein, Coronavirus
- spike protein, SARS-CoV-2
- ACE2 protein, human
- Angiotensin-Converting Enzyme 2
|
Topics |
- Angiotensin-Converting Enzyme 2
- Animals
- Antibodies, Neutralizing
(immunology)
- Antibodies, Viral
- COVID-19
(immunology, therapy, transmission)
- Cell Fusion
- Chlorocebus aethiops
- HEK293 Cells
- Humans
- Immunization, Passive
- SARS-CoV-2
(immunology)
- Spike Glycoprotein, Coronavirus
(immunology)
- Vero Cells
- Virus Internalization
- COVID-19 Serotherapy
|